All news from Anaesthesiology

Health Ministry launches Allied and Health care Professional Database

Aiming to make data repository robust, the Union Health Ministry on Monday launched the Allied and Healthcare Professional Database which will help the government to track the number of professionals and streams of allied and health care professions in the country.

According to the ministry, more than 3, 000 professionals have already registered on the portal during the testing phase.

Bladder Cancer: Treatment with Experimental 'nano-chemo' particle

Johns Hopkins researchers developed a way to successfully deliver nano-sized, platinum-based chemotherapy drugs to treat a form of bladder cancer called nonmuscle-invasive that is found in the lining of the organ and has not invaded deeper into bladder tissue. The tiny drug-infused particles, they say, potentially offer a less toxic clinical alternative to standard chemotherapy delivered intravenously or through a catheter inserted into the bladder.

To Prevent The Severity Of Colitis: Precision Editing Of Bacteria

Researchers declined that a potential strategy targets metabolic pathways that are active only during intestinal inflammation prevented or reduced inflammation in a mouse model of colitis while exerting no obvious effect in control animals with healthy, balanced bacterial populations. They have used precision editing of the bacterial populations in the gut to prevent or reduce the severity of inflammation in a mouse model of colitis.

Emerging Lyme disease in Nepal, wake-up call

Lyme disease is caused by a bacterium known as Borrellia burgdorferi and is transmitted by the bite of Ixodid tick. It is one of the most reported vector-borne diseases worldwide. Centers for Disease Control and Prevention (CDC, USA) estimated that approximately 300,000 cases of Lyme disease occur each year. 

Algal Chloroplast Produce Therapeutic Proteins

Researchers have reported that the microalgal chloroplast has clear potential as a novel industrial production platform for biopharmaceuticals. The continued development of synthetic biology tools for chloroplast engineering of C. reinhardtii will strengthen this potential by accelerating the creation of designer transgenic lines yielding high levels of the target protein.